Jonathan Maltz to lead clinical studies of HeartSentry

EE alumnus Jonathan S. Maltz (Ph.D. EE ’99) is serving as the lead researcher and Chief Scientific Advisor during the clinical trials of HeartSentry, a non-invasive diagnostic tool to measure and monitor cardiovascular health.   HeartSentry is being developed at Lexington Biosciences, a development-stage medical device company in Vancouver, Canada.  It is the product of 15-years of research at U.C. Berkeley.  Maltz has had over 16 years experience designing new devices for assessing vascular function and evaluating these on human subjects.